Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now NasdaqCM - Delayed Quote • USD Charles & Colvard, Ltd. (CTHR) Follow Add holdings 0.2500 +0.1099 +(78.44%) At close: 3:53:18 PM EDT All News Press Releases SEC Filings Charles & Colvard, Ltd. Announces Delisting from Nasdaq Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company"), announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock (the "Common Stock") from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company Charles & Colvard, Ltd. Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (Nasdaq: CTHR) today announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepte Charles & Colvard, Ltd. Receives Interim Award in Wolfspeed Arbitration Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (Nasdaq: CTHR) today announced that on December 5, 2024, it received an interim award in its confidential arbitration with Wolfspeed, Inc. Importantly, the award rejected Wolfspeed's claims to expectation damages of approximately $22.8 million, limiting the Company's damages to just $3.3 million representing approximately $1.3 million for inventory previously purchased and approximately $2.0 million of consigned inventory in the Comp Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (Nasdaq: CTHR) today announced that on November 21, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic reports (the "Listing Rule"), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support throu Charles & Colvard, Ltd. Comments on a Letter from Riverstyx Capital Management to Charles & Colvard Shareholders Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (Nasdaq: CTHR) today commented on a letter sent to the Company's shareholders and released publicly by Riverstyx Capital Management, LLC ("Riverstyx"). The Company provided the following statement in response: Zacks Initiates Coverage of Charles & Colvard With Underperform Recommendation Discover why Zacks has rated Charles & Colvard as "Underperform," being the first on Wall Street to initiate coverage on the stock. Explore the significant challenges posed by declining sales, shrinking margins, rising expenses, fierce competition and liquidity concerns, despite strategic efforts. CHARLES & COLVARD REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT Charles & Colvard, Ltd. (Nasdaq: CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, announced today that it has regained compliance with Nasdaq's minimum bid price continued listing requirement. A letter from Nasdaq Listing Qualifications Department noted that as of May 31, 2024, the minimum bid price of the Company's common stock was $1.00 per share or greater for the last 10 consecutive business/trading days. As a result, th Charles & Colvard Allies With International Gemological Institute on Grading Moissanite Stones Charles & Colvard's CEO says collaborating with IGI will maintain brand integrity in a market saturated with false information and counterfeits. CHARLES & COLVARD FORGES EXCLUSIVE STRATEGIC ALLIANCE WITH IGI TO SUPPLY MOISSANITE GRADING REPORTS Charles & Colvard, Ltd. (Nasdaq: CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, is pleased to announce an exclusive strategic alliance with the International Gemological Institute (IGI), introducing comprehensive grading reports for moissanite gemstones and jewelry. CHARLES & COLVARD ANNOUNCES REVERSE STOCK SPLIT Charles & Colvard, Ltd. (Nasdaq: CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, announced today that the Company's Board of Directors has approved a one-for-ten (1:10) reverse split of the Company's common stock, no par value per share (the "Reverse Stock Split"), to be effective as of 12:01 a.m. Eastern Time on May 17, 2024 (the "Effective Date"). The Reverse Stock Split is intended to bring the Company into compliance wi Several Insiders Invested In Charles & Colvard Flagging Positive News Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like... Charles & Colvard, Ltd. (NASDAQ:CTHR) Q3 2024 Earnings Call Transcript Charles & Colvard, Ltd. (NASDAQ:CTHR) Q3 2024 Earnings Call Transcript May 3, 2024 Charles & Colvard, Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Charles & Colvard Third Quarter Fiscal Year 2024 Earnings […] Q3 2024 Charles & Colvard Ltd Earnings Call Q3 2024 Charles & Colvard Ltd Earnings Call Charles & Colvard Ltd (CTHR) Q3 2024 Earnings Call Transcript Highlights: Navigating ... Despite a revenue decline and net loss, Charles & Colvard focuses on market expansion and operational improvements to stabilize financials. CHARLES & COLVARD REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS Charles & Colvard, Ltd. (Nasdaq: CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal 2024"). Performance Overview Trailing total returns as of 5/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return CTHR S&P 500 (^GSPC) YTD -81.20% -4.72% 1-Year -93.06% +11.67% 3-Year -98.21% +35.63%